SC
GILD icon

Sawyer & Company’s Gilead Sciences GILD Stock Holding History

Sawyer & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$29K – 177
2021
Q4 		$29K Hold
400
– – 0.01% 143
2021
Q3 		$28K Hold
400
– – 0.01% 142
2021
Q2 		$28K Buy
+400
New +$26.7K 0.01% 137
2019
Q1 		– Sell
-31
Closed -$2K – 175
2018
Q4 		$2K Hold
31
– – ﹤0.01% 175
2018
Q3 		$2K Hold
31
– – ﹤0.01% 188
2018
Q2 		$2K Hold
31
– – ﹤0.01% 190
2018
Q1 		$2K Hold
31
– – ﹤0.01% 192
2017
Q4 		$2K Buy
+31
New +$2.35K ﹤0.01% 179

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sawyer & Company's GILD Position: Q1 2022 in Review

Sawyer & Company sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 400 shares — an estimated $29K sold.

Sawyer & Company first reported a position in GILD in Q4 2017 and held it in 8 quarters. The position peaked at $29K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Sawyer & Company reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Sawyer & Company sold 400 Gilead Sciences shares in Q1 2022, an estimated $29K.
  • Sawyer & Company first reported a position in Gilead Sciences in Q4 2017 and held it in 8 quarters.
  • Sawyer & Company's Gilead Sciences position peaked at $29K in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Sawyer & Company's 13F filing for Q1 2022, filed 26 Apr 2022.